Madely Health Headlines Commentary for December 14, 2009
Source:
Drug Combo boosts advanced breast cancer survival
Comment:
This approach to treatment applies only to HER-2 breast cancers that according to the article represents 1 in 4 breast cancers.
Related articles:
- More information needed about woman’s breast cancer before slamming Ontario Government for not covering breast-cancer drug
- Promising breast cancer treatment needs supporting studies
- Estrogen-sensitive breast cancer risk reduction study finds two drugs that work but have trade-offs
- Combination therapy for invasive non-metastatic HER-2 breast cancer shows promise
- Survival rates increase for Canadians with cancer: Statscan
